Bicara Therapeutics Inc. (BCAX) announced Loss for fourth quarter that missed the Street estimates.
The company's earnings totaled -$20.96 million, or -$0.39 per share. This compares with -$12.44 million, or -$19.71 per share, last year.
Analysts on average had expected the company to earn -$0.28 per share. Analysts' estimates typically exclude special items.
Bicara Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$20.96 Mln. vs. -$12.44 Mln. last year.
-EPS: -$0.39 vs. -$19.71 last year.
For comments and feedback: editorial@rttnews.com